Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia

Sponsor
Yeditepe University (Other)
Overall Status
Completed
CT.gov ID
NCT05936983
Collaborator
(none)
90
1
18
152.2

Study Details

Study Description

Brief Summary

According to the World Health Organization; Bipolar disorder ranks in the top 20 causes of disability among all medical conditions and 6th among mental disorders worldwide. Bipolar disorder is noted as a serious mental illness involving emotional ups and downs.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Schizophrenia is a chronic mental disorder characterized by the appearance of both positive symptoms such as hallucinations and delusions and negative symptoms such as apathy and withdrawal, repetition of cognitive skills, and disorganization. In this study, it was aimed to compare physical fitness, physical activity level, depression and quality of life in bipolar disoder and schizophrenic patients with healthy individuals.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    90 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Comparison of Physical Fitness, Physical Activity Level, Depression and Quality of Life in Patients With Bipolar Disorder and Schizophrenia With Healthy Controls
    Actual Study Start Date :
    Jun 2, 2023
    Actual Primary Completion Date :
    Jun 15, 2023
    Actual Study Completion Date :
    Jun 20, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Patients with Bipolar disorder

    Participants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.

    Patients with Schizophrenia group

    Participants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.

    Healthy group

    Participants will be asked to fill out a structured questionnaire containing their sociodemographic characteristics. Then, Anthropometric Measurements, Eurofit test battery, Rapid Depressive Symptom Inventory-Self-Report Form and International physical activity questionnaire will be applied respectively.

    Outcome Measures

    Primary Outcome Measures

    1. Waist measurement - Antropometric Measurements [4 weeks]

      Waist measurement is measured from the narrowest area between the subcostal region and the iliac crest.

    2. Abdomen measurement - Antropometric Measurements [4 weeks]

      Abdomen measurement is measured at the level of the umbilicus without compression of the tissues.

    3. The hip measurement - Antropometric Measurements [4 weeks]

      The hip measurement is measured from the thickest part of the hip area.

    4. Eurofit Test Battery [4 weeks]

      A test-retest design was applied to test the reproducibility of several Eurofit test battery items. Supervision and measurement of the Eurofit test battery was performed by one trained mental health physical therapist following a standardized procedure. The Eurofit test battery included seven items and involved the assessment of the following measures: whole body balance, speed of limb movement, flexibility, explosive strength, static strength, abdominal muscular endurance and running speed.

    5. Quick Inventory of Depressive Symptomatology (QIDS-SR16) scale [4 weeks]

      QIDS-SR consists of 16 items each ranging from 0 to 3. It is scored by summing the highest response in each of a set of questions relating to sleep, weight and psychomotor symptoms and then adding the remaining items

    6. International Physical Activity Questionnaire [4 weeks]

      The IPAQ questionnaires list activities and request estimates of durations and frequencies for each activity engaged in over the past week. Durations are multiplied by known METs per activity and the results for all items are summed for the overall physical activity score. Scores for walking and for moderate and vigorous activities are sums of corresponding item scores. A sitting question is not included in physical activity score.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 55 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Individuals diagnosed with bipolar disorder and schizophrenia by a physician according to DSM-5 criteria

    • Individuals with bipolar and schizophrenia between the ages of 30-55

    • Patients without any other accompanying psychiatric disorder

    • Patients who can communicate

    • Patients who agreed to participate in this study and gave informed consent

    Exclusion Criteria:
    • Patients with a psychiatric diagnosis other than bipolar and schizophrenia.

    • Pregnancy condition

    • Those who did not consent to participate in the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yeditepe University Istanbul Turkey

    Sponsors and Collaborators

    • Yeditepe University

    Investigators

    • Principal Investigator: Ebru Akbuğa Koç, Yeditepe University
    • Principal Investigator: İsmail Koç, Kartal Dr. Lütfi Kirdar City Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yeditepe University
    ClinicalTrials.gov Identifier:
    NCT05936983
    Other Study ID Numbers:
    • 2023/514/247/4
    First Posted:
    Jul 10, 2023
    Last Update Posted:
    Jul 10, 2023
    Last Verified:
    Jun 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 10, 2023